Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Marine spatial planning makes room for offshore aquaculture in crowded coastal waters.

Lester SE, Stevens JM, Gentry RR, Kappel CV, Bell TW, Costello CJ, Gaines SD, Kiefer DA, Maue CC, Rensel JE, Simons RD, Washburn L, White C.

Nat Commun. 2018 Mar 5;9(1):945. doi: 10.1038/s41467-018-03249-1.

2.

Marine biodiversity at the end of the world: Cape Horn and Diego Ramírez islands.

Friedlander AM, Ballesteros E, Bell TW, Giddens J, Henning B, Hüne M, Muñoz A, Salinas-de-León P, Sala E.

PLoS One. 2018 Jan 24;13(1):e0189930. doi: 10.1371/journal.pone.0189930. eCollection 2018.

3.

Scale-specific drivers of kelp forest communities.

Lamy T, Reed DC, Rassweiler A, Siegel DA, Kui L, Bell TW, Simons RD, Miller RJ.

Oecologia. 2018 Jan;186(1):217-233. doi: 10.1007/s00442-017-3994-1. Epub 2017 Nov 3.

PMID:
29101467
4.

CO2 exchange and evapotranspiration across dryland ecosystems of southwestern North America.

Biederman JA, Scott RL, Bell TW, Bowling DR, Dore S, Garatuza-Payan J, Kolb TE, Krishnan P, Krofcheck DJ, Litvak ME, Maurer GE, Meyers TP, Oechel WC, Papuga SA, Ponce-Campos GE, Rodriguez JC, Smith WK, Vargas R, Watts CJ, Yepez EA, Goulden ML.

Glob Chang Biol. 2017 Oct;23(10):4204-4221. doi: 10.1111/gcb.13686. Epub 2017 Apr 19.

PMID:
28295911
5.

Drivers of redistribution of fishing and non-fishing effort after the implementation of a marine protected area network.

Cabral RB, Gaines SD, Johnson BA, Bell TW, White C.

Ecol Appl. 2017 Mar;27(2):416-428. doi: 10.1002/eap.1446. Epub 2017 Feb 16.

PMID:
28207172
6.

Fluctuations in population fecundity drive variation in demographic connectivity and metapopulation dynamics.

Castorani MC, Reed DC, Raimondi PT, Alberto F, Bell TW, Cavanaugh KC, Siegel DA, Simons RD.

Proc Biol Sci. 2017 Jan 25;284(1847). pii: 20162086. doi: 10.1098/rspb.2016.2086.

7.

Offshore aquaculture: Spatial planning principles for sustainable development.

Gentry RR, Lester SE, Kappel CV, White C, Bell TW, Stevens J, Gaines SD.

Ecol Evol. 2016 Dec 24;7(2):733-743. doi: 10.1002/ece3.2637. eCollection 2017 Jan. Review.

8.

A Proteomic Survey Indicates Sortilin as a Secondary Substrate of the ER Translocation Inhibitor Cyclotriazadisulfonamide (CADA).

Van Puyenbroeck V, Claeys E, Schols D, Bell TW, Vermeire K.

Mol Cell Proteomics. 2017 Feb;16(2):157-167. doi: 10.1074/mcp.M116.061051. Epub 2016 Dec 20.

9.

Proton-Gated Photoisomerization of Amino-Substituted Dibenzofulvene Rotors.

Jayasundara UK, Kim H, Sahteli KP, Cline JI, Bell TW.

Chemphyschem. 2017 Jan 4;18(1):59-63. doi: 10.1002/cphc.201601214. Epub 2016 Dec 13.

PMID:
27862796
10.

Synthesis and Photoisomerization of Substituted Dibenzofulvene Molecular Rotors.

Everhart SC, Jayasundara UK, Kim H, Procúpez-Schtirbu R, Stanbery WA, Mishler CH, Frost BJ, Cline JI, Bell TW.

Chemistry. 2016 Aug 1;22(32):11291-302. doi: 10.1002/chem.201600854. Epub 2016 Jul 1.

PMID:
27363530
11.

Tuning Side Arm Electronics in Unsymmetrical Cyclotriazadisulfonamide (CADA) Endoplasmic Reticulum (ER) Translocation Inhibitors to Improve their Human Cluster of Differentiation 4 (CD4) Receptor Down-Modulating Potencies.

Chawla R, Van Puyenbroeck V, Pflug NC, Sama A, Ali R, Schols D, Vermeire K, Bell TW.

J Med Chem. 2016 Mar 24;59(6):2633-47. doi: 10.1021/acs.jmedchem.5b01832. Epub 2016 Mar 14.

PMID:
26974263
12.

Connectivity structures local population dynamics: a long-term empirical test in a large metapopulation system.

Castorani MC, Reed DC, Alberto F, Bell TW, Simons RD, Cavanaugh KC, Siegel DA, Raimondi PT.

Ecology. 2015 Dec;96(12):3141-52.

PMID:
26909421
13.

Terrestrial carbon balance in a drier world: the effects of water availability in southwestern North America.

Biederman JA, Scott RL, Goulden ML, Vargas R, Litvak ME, Kolb TE, Yepez EA, Oechel WC, Blanken PD, Bell TW, Garatuza-Payan J, Maurer GE, Dore S, Burns SP.

Glob Chang Biol. 2016 May;22(5):1867-79. doi: 10.1111/gcb.13222. Epub 2016 Feb 15.

14.

Seascape drivers of Macrocystis pyrifera population genetic structure in the northeast Pacific.

Johansson ML, Alberto F, Reed DC, Raimondi PT, Coelho NC, Young MA, Drake PT, Edwards CA, Cavanaugh K, Assis J, Ladah LB, Bell TW, Coyer JA, Siegel DA, Serrão EA.

Mol Ecol. 2015 Oct;24(19):4866-85. doi: 10.1111/mec.13371.

PMID:
26339775
15.

Metal complexes of pyridine-fused macrocyclic polyamines targeting the chemokine receptor CXCR4.

Hamal S, D'huys T, Rowley WF, Vermeire K, Aquaro S, Frost BJ, Schols D, Bell TW.

Org Biomol Chem. 2015 Nov 14;13(42):10517-26. doi: 10.1039/c5ob01557j. Epub 2015 Sep 4.

PMID:
26338723
16.

Signal peptide-binding drug as a selective inhibitor of co-translational protein translocation.

Vermeire K, Bell TW, Van Puyenbroeck V, Giraut A, Noppen S, Liekens S, Schols D, Hartmann E, Kalies KU, Marsh M.

PLoS Biol. 2014 Dec 2;12(12):e1002011. doi: 10.1371/journal.pbio.1002011. eCollection 2014 Dec.

17.

Cadmium and Zinc Alloyed Cu-In-S Nanocrystals and Their Optical Properties.

Huang L, Zhu X, Publicover NG, Hunter KW Jr, Ahmadiantehrani M, de Bettencourt-Dias A, Bell TW.

J Nanopart Res. 2013 Nov 1;15(11). doi: 10.1007/s11051-013-2056-9.

18.

Improving potencies and properties of CD4 down-modulating CADA analogs.

Bell TW, Demillo VG, Schols D, Vermeire K.

Expert Opin Drug Discov. 2012 Jan;7(1):39-48. doi: 10.1517/17460441.2012.643865. Epub 2011 Dec 6. Review.

PMID:
22468892
19.

Unsymmetrical cyclotriazadisulfonamide (CADA) compounds as human CD4 receptor down-modulating agents.

Demillo VG, Goulinet-Mateo F, Kim J, Schols D, Vermeire K, Bell TW.

J Med Chem. 2011 Aug 25;54(16):5712-21. doi: 10.1021/jm2002603. Epub 2011 Jul 29.

PMID:
21800875
20.

Controlling the spatial orientation of molecular actuators: polarized photoisomerization of 2-nitro-9-(2,2,2-triphenylethylidene)fluorene in a thin polymer matrix.

Ismail AI, Mantha JH, Kim HJ, Bell TW, Cline JI.

J Phys Chem A. 2011 Feb 3;115(4):419-27. doi: 10.1021/jp1054777. Epub 2011 Jan 6.

PMID:
21210693
21.

Drugs for hepatitis C: unlocking a new mechanism of action.

Bell TW.

ChemMedChem. 2010 Oct 4;5(10):1663-5. doi: 10.1002/cmdc.201000334. No abstract available.

PMID:
20821796
22.

Differential activity of candidate microbicides against early steps of HIV-1 infection upon complement virus opsonization.

Jenabian MA, Saïdi H, Charpentier C, Bouhlal H, Schols D, Balzarini J, Bell TW, Vanham G, Bélec L.

AIDS Res Ther. 2010 Jun 14;7:16. doi: 10.1186/1742-6405-7-16.

23.

Human immunodeficiency virus type 1 escape from cyclotriazadisulfonamide-induced CD4-targeted entry inhibition is associated with increased neutralizing antibody susceptibility.

Vermeire K, Van Laethem K, Janssens W, Bell TW, Schols D.

J Virol. 2009 Sep;83(18):9577-83. doi: 10.1128/JVI.00648-09. Epub 2009 Jul 1.

24.

CADA, a potential anti-HIV microbicide that specifically targets the cellular CD4 receptor.

Vermeire K, Brouwers J, Van Herrewege Y, Le Grand R, Vanham G, Augustijns P, Bell TW, Schols D.

Curr HIV Res. 2008 May;6(3):246-56.

PMID:
18473788
25.

Design and cellular kinetics of dansyl-labeled CADA derivatives with anti-HIV and CD4 receptor down-modulating activity.

Vermeire K, Lisco A, Grivel JC, Scarbrough E, Dey K, Duffy N, Margolis L, Bell TW, Schols D.

Biochem Pharmacol. 2007 Aug 15;74(4):566-78. Epub 2007 May 29.

PMID:
17603023
26.

Another proposal for primary care.

Bell TW.

CMAJ. 2006 May 23;174(11):1597. No abstract available.

27.

Inhibitors of HIV infection via the cellular CD4 receptor.

Vermeire K, Schols D, Bell TW.

Curr Med Chem. 2006;13(7):731-43. Review.

PMID:
16611063
28.

Synthesis and structure-activity relationship studies of CD4 down-modulating cyclotriazadisulfonamide (CADA) analogues.

Bell TW, Anugu S, Bailey P, Catalano VJ, Dey K, Drew MG, Duffy NH, Jin Q, Samala MF, Sodoma A, Welch WH, Schols D, Vermeire K.

J Med Chem. 2006 Feb 23;49(4):1291-312.

PMID:
16480266
29.

Syntheses, structures, and photoisomerization of (E)- and (Z)-2-tert-butyl-9-(2,2,2-triphenylethylidene)fluorene.

Barr JW, Bell TW, Catalano VJ, Cline JI, Phillips DJ, Procupez R.

J Phys Chem A. 2005 Dec 29;109(51):11650-4.

PMID:
16366613
30.

A proposal for health care reform.

Bell TW.

Physician Exec. 2005 Sep-Oct;31(5):28-30.

PMID:
16224903
31.

Supramolecular optical chemosensors for organic analytes.

Bell TW, Hext NM.

Chem Soc Rev. 2004 Nov 30;33(9):589-98. Epub 2004 Nov 2. Review.

PMID:
15592624
32.

CADA, a novel CD4-targeted HIV inhibitor, is synergistic with various anti-HIV drugs in vitro.

Vermeire K, Princen K, Hatse S, De Clercq E, Dey K, Bell TW, Schols D.

AIDS. 2004 Nov 5;18(16):2115-25.

PMID:
15577644
33.

CD4 down-modulating compounds with potent anti-HIV activity.

Vermeire K, Schols D, Bell TW.

Curr Pharm Des. 2004;10(15):1795-803. Review.

PMID:
15180541
34.

Syntheses, conformations, and basicities of bicyclic triamines.

Bell TW, Choi HJ, Harte W, Drew MG.

J Am Chem Soc. 2003 Oct 8;125(40):12196-210.

PMID:
14519005
35.

Bond angle versus torsional deformation in an overcrowded alkene: 9-(2,2,2-triphenylethylidene)fluorene.

Bell TW, Catalano VJ, Drew MG, Phillips DJ.

Chemistry. 2002 Nov 4;8(21):5001-6.

PMID:
12489533
36.

The Anti-HIV potency of cyclotriazadisulfonamide analogs is directly correlated with their ability to down-modulate the CD4 receptor.

Vermeire K, Bell TW, Choi HJ, Jin Q, Samala MF, Sodoma A, De Clercq E, Schols D.

Mol Pharmacol. 2003 Jan;63(1):203-10.

37.

CADA inhibits human immunodeficiency virus and human herpesvirus 7 replication by down-modulation of the cellular CD4 receptor.

Vermeire K, Zhang Y, Princen K, Hatse S, Samala MF, Dey K, Choi HJ, Ahn Y, Sodoma A, Snoeck R, Andrei G, De Clercq E, Bell TW, Schols D.

Virology. 2002 Oct 25;302(2):342-53.

38.

Role of pyridine hydrogen-bonding sites in recognition of basic amino acid side chains.

Bell TW, Khasanov AB, Drew MG.

J Am Chem Soc. 2002 Nov 27;124(47):14092-103.

PMID:
12440908
39.

Reversible photoinsertion of ferrocene into a hydrophobic semiconductor surface: a chemionic switch.

Muraoka M, Gillett SL, Bell TW.

Angew Chem Int Ed Engl. 2002 Oct 4;41(19):3653-6, 3519. No abstract available.

PMID:
12370920
40.

Circular dichroism readout of sugar recognition in the cleft of a fused-pyridine receptor.

Tamaru S, Shinkai S, Khasanov AB, Bell TW.

Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):4972-6.

41.

A hydrogen-bonding receptor that binds cationic monosaccharides with high affinity in methanol.

Tamaru SI, Yamamoto M, Shinkai S, Khasanov AB, Bell TW.

Chemistry. 2001 Dec 17;7(24):5270-6.

PMID:
11822427
42.

Synthesis of 1,2,3,4,5,6,7,8-octahydroacridine via condensation of cyclohexanone with formaldehyde.

Pilato ML, Catalano VJ, Bell TW.

J Org Chem. 2001 Feb 23;66(4):1525-7. No abstract available.

PMID:
11312996
43.

A Small-Molecule Guanidinium Receptor: The Arginine Cork.

Bell TW, Khasanov AB, Drew MG, Filikov A, James TL.

Angew Chem Int Ed Engl. 1999 Sep;38(17):2543-2547.

PMID:
10508332
44.

Carriers and channels: current progress and future prospects.

Bell TW.

Curr Opin Chem Biol. 1998 Dec;2(6):711-6. Review.

PMID:
9914195
45.

Molecular trees: a new branch of chemistry.

Bell TW.

Science. 1996 Feb 23;271(5252):1077-8. Review. No abstract available.

PMID:
8599080
46.

Detection of creatinine by a designed receptor.

Bell TW, Hou Z, Luo Y, Drew MG, Chapoteau E, Czech BP, Kumar A.

Science. 1995 Aug 4;269(5224):671-4.

PMID:
7624796
47.

Self-assembly of a double-helical complex of sodium.

Bell TW, Jousselin H.

Nature. 1994 Feb 3;367(6462):441-4.

PMID:
8107802
48.
49.
50.

Stereochemical course of pheromone biosynthesis in the arctiid moth, Creatonotos transiens.

Bell TW, Boppré M, Schneider D, Meinwald J.

Experientia. 1984 Jul 15;40(7):713-4.

PMID:
6540200

Supplemental Content

Support Center